BioClonal is focused in Antibody Discovery, offering customized solutions tailored to each specifics needs and goals in the therapeutic mAbs area. Proprietary development: FIC for Alzheimer's Disease We partner with pharmaceutical and biotechnology companies worldwide, solving or minimizing affinity, specifity and developability problems, thanks to our innovative technologies and in vivo platforms, RedMabs and NextMabs. No matter what it is, your challenge is our breakthrough and our mission is to empower your mab to the extraordinary, providing Real Biobetters, better therapeutic mabs for our partners. Based in a win- win philosophy, we propose long-term agreements of co-discovery and co-development.
